Continuous glucose monitoring (CGM) is a small wearable device that tracks blood glucose throughout the day and night, notifying the highs and lows in order to take better treatment decisions and better glucose control. These continuous glucose monitoring systems (CGMS) use wireless technology for transmitting glucose readings collected from the interstitial fluid between the patient’s skin cells, unlike blood glucose meters that measure glucose levels in the blood. CGMs are identified as one of the most important emerging tools for diabetes management, especially type I diabetes in which patients are completely insulin dependent. CGM helps to minimize the guesswork that comes from making decisions based solely on a number from a blood glucose meter reading, for better diabetes management.
The global continuous glucose monitoring market report provides market size (Revenue USD Million 2014 to 2021), market share, market trends and forecasts growth trends (CAGR%, 2017 to 2021).
The global continuous glucose monitoring market segmentation is based on product types (Guardian Real Time CGM System, FreeStyle Navigator, Dexcom Seven Plus CGM System, Dexcom G4 Platinum, MiniMed Paradigm Revel/Veo System).
The global continuous glucose monitoring market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global continuous glucose monitoring market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global continuous glucose monitoring market and included in this report are Medtronic, Inc., Dexcom, Inc., Abbott Laboratories, Inc., Bayer AG, Nova Biomedical Corporation, Senseonics, Incorporated, GlySens, Incorporated and Insulet Corporation.